Document Detail


Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.
MedLine Citation:
PMID:  11032025     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Proliferation of MCF-7 cells is estrogen dependent and antiestrogen sensitive. In the absence of estrogens or presence of antiestrogens MCF-7 cells arrest in the G1 phase of the cell cycle, and this arrest is associated with an accumulation of the active, hypophosphorylated form of the retinoblastoma protein (pRb). Because active pRb negatively regulates passage from G1 to S phase, this suggests that pRb is a crucial target of estrogen action, and that its inactivation might lead to antiestrogen resistance. We tested this hypothesis by expressing viral tumor antigens (T antigens), which bind and inactivate pRb, in MCF-7 cells, and determining the effects on cell proliferation in the presence of antiestrogens. The results of these experiments demonstrate that T antigen expression confers antiestrogen resistance to MCF-7 cells. Using a panel of mutant T antigens, we further demonstrate that the pRb-binding, but not the p53 binding domain is required to confer antiestrogen resistance. Thus, pRb is an important target of estrogen action, and its inactivation can contribute to the development of antiestrogen resistance.
Authors:
H Varma; S E Conrad
Related Documents :
12017335 - Role of ribonucleotide reductase in regulation of cell cycle progression during and aft...
6370255 - Glyoxalase-i activity and cell cycle regulation in yeast.
3592635 - Mode of estrogen action on cell proliferation in cama-1 cells: iii. effect of antiestro...
1639135 - Lithium mimics dexamethasone in stimulating dna synthesis by wi-38 cells.
8519685 - Induction of cell death in murine fibroblasts by a c-myc promoter binding protein.
19118505 - Generation and regulation of cd8(+) regulatory t cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Oncogene     Volume:  19     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-11-13     Completed Date:  2000-11-13     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  4746-53     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, Michigan State University, East Lansing 48824-1101, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / pathology*
Antigens, Polyomavirus Transforming / metabolism,  physiology*
Antineoplastic Agents, Hormonal / pharmacology*
Breast Neoplasms / pathology*
Cyclin D1 / physiology
Drug Resistance, Neoplasm
Estradiol / analogs & derivatives*,  pharmacology
Estrogen Receptor Modulators / pharmacology*
Estrogens*
Female
G1 Phase / drug effects
Humans
Neoplasm Proteins / antagonists & inhibitors,  physiology*
Neoplasms, Hormone-Dependent / pathology*
Protein Structure, Tertiary
Recombinant Fusion Proteins / physiology
Retinoblastoma Protein / antagonists & inhibitors,  physiology*
Tamoxifen / analogs & derivatives*,  pharmacology
Transfection
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
CA76647/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Polyomavirus Transforming; 0/Antineoplastic Agents, Hormonal; 0/Estrogen Receptor Modulators; 0/Estrogens; 0/Neoplasm Proteins; 0/Recombinant Fusion Proteins; 0/Retinoblastoma Protein; 10540-29-1/Tamoxifen; 136601-57-5/Cyclin D1; 17197F0KYM/afimoxifene; 22X328QOC4/fulvestrant; 50-28-2/Estradiol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of a novel quiescence responsive element downregulated by v-Src in the promoter of ...
Next Document:  Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-fola...